| S-EMCA |
6ALPHA-乙基-23(S)-甲基胆酸 |
1199796-29-6 |
| LDN-211904 |
N-(2-氯苯基)-6-(4-哌啶基)-咪唑并[1,2-A]吡啶-3-甲酰胺 |
1198408-39-7 |
| MRS 2211 |
MRS 2211 |
1197030-56-0 |
| IQ-R |
CS-2066 |
1345445-57-9 |
| MC-Val-Ala-PBD |
MC-Val-Ala-PBD |
1342820-51-2 |
| BP-1-102 |
4-(N-(4-环己基苄基)-2-((2,3,4,5,6-五氟-N-甲苯基)磺酰氨基)乙酰氨基)-2-羟基苯甲酸 |
1334493-07-0 |
| 1H-1,2,3-Triazole-1-acetic acid, 4-[[bis[[1-(1,1-diMethylethyl)-1H-1,2,3-triazol-4-yl]Methyl]aMino]Methyl]- |
BTTAA |
1334179-85-9 |
| CHR-6494 |
3-(1H-吲唑-5-基)-N-丙基咪唑并[1,2-B]哒嗪-6-胺 |
1333377-65-3 |
| M2 ion channel blocker |
N-(金刚烷-1-基甲基)-L-组氨酸甲酯 |
1190215-03-2 |
| (S)-Gossypol (acetic acid) |
1189561-66-7 |
1189561-66-7 |
| PF 4800567 hydrochloride |
无中文名称 |
1188296-52-7 |
| MK-2 Inhibitor III |
MK-2 INHIBITOR III (COMPOUND 16) |
1186648-22-5 |
| DBPR108 |
化合物DBPR108 |
1186426-66-3 |
| KN-92 |
KN-92 |
1283519-40-3 |
| EMD638683 |
3,5-二氟-ALPHA-羟基-苯乙酸 2-(2-乙基-4-羟基-3-甲基苯甲酰)酰肼 |
1181770-72-8 |
| (3beta,12beta)-20-(beta-D-Glucopyranosyloxy)-12-hydroxydammara-5,24-dien-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside |
5,6-二去氢人参皂苷 RD |
1268459-68-2 |
| CCT241533 |
(3R,4S)-4-[[2-(5-氟-2-羟基苯基)-6,7-二甲氧基-4-喹唑啉基]氨基]-ALPHA,ALPHA-二甲基-3-吡咯烷甲醇 |
1262849-73-9 |
| INDY |
INDY |
1169755-45-6 |
| RuBi-Nicotine |
化合物 T23279 |
1256362-30-7 |
| PSI-6206 13CD3 |
(2'R)-2'-脱氧-2'-氟-2'-(三氘甲基-C)尿苷 |
1256490-42-2 |
